BioPharma Pharma Research

Tempus Collaborates with Bristol Myers Squibb on Multimodal AI Research

"We are looking forward to expanding our relationship with Bristol Myers Squibb and furthering our shared commitment to advancing cancer research and treat...

 November 09, 2023 | News

Bayer and Broad Institute of MIT and Harvard Extend Research Collaboration to Develop New Cancer Therapies

Agreement to focus on joint cancer target identification and discovery of new therapeutic approaches Extended collaboration strengthens Bayer's precisio...

 November 03, 2023 | News

CStone Partners with 3SBio for Nofazinlimab in China

CStone to grant 3SBio exclusive rights for the development, registration, manufacturing, and commercialization of nofazinlimab (anti-PD-1 antibody) in ma...

 November 02, 2023 | News

Clario's Opal® Technology Drives Breakthrough in Parkinson's Disease at University of Oxford

Clario's Precision Motion Opal® wearable sensor technology detects early Parkinson's disease (PD) progression in a Univ...

 October 30, 2023 | News

Cytiva and RoosterBio collaborate to address exosome manufacturing challenges

  Aiming to improve exosome purification process that is currently slowing adoption of promising gene therapies and other new modalities A scalabl...

 October 30, 2023 | News

Henlius Expands Partnership with Intas to Introduce Serplulimab in Europe and India

Intas to develop and commercialise serplulimab in Europe and India; Henlius to receive €42 million upfront payment, double-digit royalt...

 October 30, 2023 | News

Lunit Enters into Research Collaboration to Explore the Use of AI to Improve the Effectiveness of Immunotherapy

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced a research collaboration with The ...

 October 30, 2023 | News

Sirio Pharma and Best Formulations Announce U.S. Gummy Manufacturing Capabilities

Sirio Pharma Co., Ltd. (Sirio), a leading global CDMO, is pleased to announce the addition of new gummy manufacturing capabilities at its Best Formulations...

 October 20, 2023 | News

Ascentage Pharma & AstraZeneca Collaborate on Phase III Study for CLL/SLL Treatment

The two companies will jointly conduct a registrational Phase III study of the Bcl-2 inhibitor, APG-2575 (lisaftoclax), in combination with AstraZeneca's B...

 October 16, 2023 | News

HanAll, Daewoong, and NurrOn Launch Phase 1 Study for HL192

HanAll Biopharma and Daewoong Pharmaceutical marked a pivotal step forward in the development of HL192 (ATH-399A) for the potential treatment of Parkinso...

 October 13, 2023 | News

GE HealthCare Expands Human Subject Research with Stanford Medicine Using Photon Counting CTi Technology

Unique from current CT technology, GE HealthCare’s proprietary photon counting CT design is engineered to leverage Deep Silicon detectors with the ...

 October 10, 2023 | News

Kexing Biopharm Hosts High-end Forum for China-MENA & South Asia Pharma Cooperation in Emerging Markets

MENA and South Asia are recognized as pivotal regions for Kexing Biopharm's overseas business expansion. The event brought together industry experts and he...

 October 10, 2023 | News

Everest Medicines' Partner Calliditas Shares NefIgArd Phase 3 Trial Data at ISIN Tokyo 2023

"The positive findings from biomarker and patient subgroup analyses from the Phase 3 NefIgArd study highlights that Nefecon® treatment results in ...

 October 05, 2023 | News

ZEISS and Boehringer Ingelheim Collaborate on Early Eye Disease Detection to Prevent Vision Loss.

The partnership brings together their leading expertise in ophthalmological technology, data analytics, algorithms and the development of first-in-class tr...

 October 03, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in